Kala Pharmaceuticals, Inc (KALA) Stock Price

0.9241 ▲ +0.0401 (+4.54%)
Open: 0.896 Vol: 0 Day's range: 0.8806 - 0.9241 Aug 13, 15:42 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
KALA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.90▲ 0.90▲ 0.90▲ 0.83▲ 0.77▲
MA10 0.89▲ 0.89▲ 0.88▲ 0.79▲ 1.55▼
MA20 0.84▲ 0.82▲ 0.81▲ 0.74▲ 3.50▼
MA50 0.79▲ 0.77▲ 0.75▲ 1.57▼ 90.60▼
MA100 0.73▲ 0.75▲ 0.83▲ 3.99▼ 201.22▼
MA200 0.85▲ 1.06▼ 1.56▼ 16.54▼ 357.76▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.004▲ 0.008▲ 0.010▲ 0.098▲ 6.266▲
RSI 70.574▲ 71.813▲ 75.505▲ 43.066▼ 33.860▼
STOCH 83.247▲ 90.656▲ 92.099▲ 66.177     3.906▼
WILL %R 0.000▲ 0.000▲ 0.000▲ -7.731▲ -90.080▼
CCI 105.315▲ 95.299     95.596     173.648▲ -80.613    
Latest Filters Detected On KALA
BBANDS $KALA Bollinger Bands Contracting Set Alert
MA $KALA Price Crossed Above MA(26) Set Alert
▲ GAP $KALA Open Gap Up %5 Set Alert
▲ GAP $KALA Open Gap Up %3 Set Alert
▲ GAP $KALA Open Gap Up %2 Set Alert
▲ BREAK $KALA Price Breaks 10 Days High Set Alert
Kala Pharmaceuticals, Inc News
Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities
Tuesday, March 31, 2026 05:00 PM
TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Kala Bio Inc. (NASDAQ: KALA), a clinical-stage biopharmaceutical company at the forefront of artificial intelligence and cell and gene therapy innovation, ...
KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live
Monday, March 30, 2026 05:45 AM
ARLINGTON, Mass., March 30, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) (“Kala” or the “Company”) today announced the initial commercial deployment of the Bionic Intelligence Research Agent ...
Is KALA BIO On The Verge Of A Pivotal Moment With KPI-012?
Friday, September 05, 2025 02:28 AM
(RTTNews) - KALA BIO Inc. (KALA) is in focus, as anticipation builds around its upcoming clinical trial data for KPI-012, a novel stem cell-derived therapy targeting persistent corneal epithelial ...
KALA historical stock data
date open high low close volume
13/08/26 0.896 0.9241 0.8806 0.9241 96,461
12/08/26 0.897 0.95 0.819 0.884 62,840
11/08/26 0.755 0.845 0.75 0.8449 81,120
10/08/26 0.778 0.8186 0.7254 0.755 124,514
07/08/26 0.7504 0.777 0.72 0.7478 43,147
06/08/26 0.73 0.7511 0.7065 0.7368 47,718
05/08/26 0.75 0.766 0.6951 0.701 40,464
04/08/26 0.83 0.859 0.7418 0.743 127,610
03/08/26 0.78 0.88 0.72 0.783 57,212
31/07/26 0.732 0.7875 0.67 0.7559 71,725
Quote Details
52wk Low:0.59
52wk High:1,030.00
Vol:0
Avg Vol(3m):2.6M
1Y Chng:-99.84%
1M Chng:-44.99%
Add to Watch List
More Information
Index US Composite
Market Cap. 16.34M